WallStreetZenWallStreetZen

NASDAQ: HTGM
Htg Molecular Diagnostics Inc Stock

Open Broker Account
$0.25+0.01 (+4.17%)
Updated Dec 8, 2022
HTGM Price
$0.25
Fair Value Price
$0.57
Market Cap
$2.74M
52 Week Low
$0.20
52 Week High
$5.68
P/E
-0.1x
P/B
2.27x
P/S
1x
PEG
N/A
Dividend Yield
N/A
Revenue
$6.80M
Earnings
-$22.09M
Gross Margin
42.7%
Operating Margin
-310.54%
Profit Margin
-324.7%
Debt to Equity
10.26
Operating Cash Flow
-$20M
Beta
0.93
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

HTGM Overview

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.

Zen Score

Industry Average (31)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how HTGM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HTGM ($0.25) is undervalued by 56.17% relative to our estimate of its Fair Value price of $0.57 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
HTGM ($0.25) is significantly undervalued by 56.17% relative to our estimate of its Fair Value price of $0.57 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
HTGM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more HTGM due diligence checks available for Premium users.

Be the first to know about important HTGM news, forecast changes, insider trades & much more!

HTGM News

Valuation

HTGM fair value

Fair Value of HTGM stock based on Discounted Cash Flow (DCF)
Price
$0.25
Fair Value
$0.57
Undervalued by
55.81%
HTGM ($0.25) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HTGM ($0.25) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HTGM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

HTGM price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.1x
Industry
37.24x
Market
21.39x

HTGM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.27x
Industry
4.43x
HTGM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

HTGM's financial health

Profit margin

Revenue
$1.3M
Net Income
-$4.5M
Profit Margin
-361%
HTGM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
HTGM's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$13.6M
Liabilities
$12.4M
Debt to equity
10.26
HTGM's short-term assets ($10.77M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HTGM's short-term assets ($10.77M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HTGM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HTGM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.6M
Investing
$5.1M
Financing
-$3.1M
HTGM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

HTGM vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
HTGM$2.74M+3.33%-0.10x2.27x
QTNT$2.12M+1.01%-0.01x-0.01x
SQL$4.72M-1.24%-1.17x0.86x
MOTS$5.59M+1.69%-0.12x7.33x
OPGN$6.44M-7.69%-0.13x0.46x

Htg Molecular Diagnostics Stock FAQ

What is Htg Molecular Diagnostics's quote symbol?

NASDAQ: HTGM) Htg Molecular Diagnostics trades on the NASDAQ under the ticker symbol HTGM. Htg Molecular Diagnostics stock quotes can also be displayed as NASDAQ: HTGM.

If you're new to stock investing, here's how to buy Htg Molecular Diagnostics stock.

What is the 52 week high and low for Htg Molecular Diagnostics (NASDAQ: HTGM)?

(NASDAQ: HTGM) Htg Molecular Diagnostics's 52-week high was $5.68, and its 52-week low was $0.20. It is currently -95.63% from its 52-week high and 24.62% from its 52-week low.

How much is Htg Molecular Diagnostics stock worth today?

(NASDAQ: HTGM) Htg Molecular Diagnostics currently has 11,049,948 outstanding shares. With Htg Molecular Diagnostics stock trading at $0.25 per share, the total value of Htg Molecular Diagnostics stock (market capitalization) is $2.74M.

Htg Molecular Diagnostics stock was originally listed at a price of $13.77 in May 6, 2015. If you had invested in Htg Molecular Diagnostics stock at $13.77, your return over the last 7 years would have been -98.2%, for an annualized return of -43.66% (not including any dividends or dividend reinvestments).

How much is Htg Molecular Diagnostics's stock price per share?

(NASDAQ: HTGM) Htg Molecular Diagnostics stock price per share is $0.25 today (as of Dec 8, 2022).

What is Htg Molecular Diagnostics's Market Cap?

(NASDAQ: HTGM) Htg Molecular Diagnostics's market cap is $2.74M, as of Dec 10, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Htg Molecular Diagnostics's market cap is calculated by multiplying HTGM's current stock price of $0.25 by HTGM's total outstanding shares of 11,049,948.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.